Animalcare Group (LSE:ANCR) ROCE % : 2.58% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Animalcare Group ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Animalcare Group's annualized ROCE % for the quarter that ended in Dec. 2023 was 2.58%.

Animalcare Group ROCE % Historical Data

The historical data trend for Animalcare Group's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Animalcare Group ROCE % Chart

Animalcare Group Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-0.85

0.66

1.39

3.12

4.64

Animalcare Group Semi-Annual Data
	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial															-1.07	8.64	-2.40	6.49	2.58

Animalcare Group ROCE % Calculation

Animalcare Group's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	4.273	/	( ( (118.242 - 22.275)	+	(106.792 - 18.418) )	/ 2 )
	=	4.273	/	( (95.967	+	88.374)	/ 2 )
	=	4.273	/	92.1705
	=	4.64 %

Animalcare Group's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	2.362	/	( ( (113.786 - 19.045)	+	(106.792 - 18.418) )	/ 2 )
	=	2.362	/	( ( 94.741	+	88.374 )	/ 2 )
	=	2.362	/	91.5575
	=	2.58 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Animalcare Group (LSE:ANCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Animalcare Group ROCE % Related Terms

Thank you for viewing the detailed overview of Animalcare Group's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Animalcare Group (LSE:ANCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Animalcare Group PLC (LSE:ANCR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

ANCR.GB:UK

Address

Monks Cross Drive, Moorside, York, GBR, YO32 9LB

Website

https://www.animalcaregroup.com

Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. Its only reportable segment is Pharmaceutical which includes the development and marketing of innovative pharmaceutical products. The company has a presence in Belgium, The Netherlands, Germany, Italy, Portugal, European Union - Other, Asia, Middle East Africa, Spain, the United Kingdom, and Other Countries of which Spain derives a majority of revenue to the company.

Animalcare Group (LSE:ANCR) Headlines

No Headlines